Quantitative autoradiographic distribution of [3H]mazindol-labeled dopamine uptake sites in the brains of superoxide dismutase transgenic mice

[1]  J. Cadet,et al.  Regional effects of 6-hydroxydopamine (6-OHDA) on free radical scavengers in rat brain , 1989, Brain Research.

[2]  A. Graybiel,et al.  Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[3]  O. Elroy-Stein,et al.  Diminished serotonin uptake in platelets of transgenic mice with increased Cu/Zn‐superoxide dismutase activity. , 1989, The EMBO journal.

[4]  B. Yamamoto,et al.  In vivo neurochemical and anatomical heterogeneity of the dopamine uptake system in the rat caudate putamen , 1989, Brain Research.

[5]  J. Cadet,et al.  Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: Behavioral and biochemical evidence , 1989, Brain Research.

[6]  F. Zemlan,et al.  Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation , 1989, Brain Research.

[7]  E. Hall,et al.  Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. , 1989, Free radical biology & medicine.

[8]  A. Davison,et al.  Intermediates in the aerobic autoxidation of 6-hydroxydopamine: relative importance under different reaction conditions. , 1989, Free radical biology & medicine.

[9]  D. Jamieson,et al.  Oxygen toxicity and reactive oxygen metabolites in mammals. , 1989, Free radical biology & medicine.

[10]  J. Cadet.  A unifying theory of movement and madness: involvement of free radicals in disorders of the isodendritic core of the brainstem. , 1988, Medical hypotheses.

[11]  R. Marttila,et al.  Oxygen toxicity protecting enzymes in Parkinson's disease Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus , 1988, Journal of the Neurological Sciences.

[12]  O. Elroy-Stein,et al.  Impaired neurotransmitter uptake in PC12 cells overexpressing human Cu/Zn-superoxide dimutase-implication for gene dosage effects in down syndrome , 1988, Cell.

[13]  J. Cadet.  Free radical mechanisms in the central nervous system: an overview. , 1988, The International journal of neuroscience.

[14]  M. Roberfroid,et al.  Free radicals in drug research , 1988 .

[15]  C. Gerfen,et al.  The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  M. Lovett,et al.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Davies.  Protein damage and degradation by oxygen radicals. I. general aspects. , 1987, The Journal of biological chemistry.

[18]  D. Pollen,et al.  The genetic defect causing familial Alzheimer's disease maps on chromosome 21. , 1987, Science.

[19]  S. Gershon,et al.  Hammond and lithium: Historical update , 1986, Biological Psychiatry.

[20]  F. Zemlan,et al.  Superoxide dismutase, chromosome 21, and Alzheimer's disease , 1986, Biological Psychiatry.

[21]  Y. Bernstein,et al.  Human Cu/Zn superoxide dismutase gene family: molecular structure and characterization of four Cu/Zn superoxide dismutase-related pseudogenes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  W. Pryor.  Oxy-radicals and related species: their formation, lifetimes, and reactions. , 1986, Annual review of physiology.

[23]  I. Fridovich,et al.  Inactivation of glutathione peroxidase by superoxide radical. , 1985, Archives of biochemistry and biophysics.

[24]  S. Snyder,et al.  Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiography , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  S. Snyder,et al.  Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Cerutti.  Prooxidant states and tumor promotion. , 1985, Science.

[27]  O. Stein,et al.  Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase. , 1985, The EMBO journal.

[28]  A. Girotti.  Mechanisms of lipid peroxidation. , 1985, Journal of free radicals in biology & medicine.

[29]  D. Harman.  Free radical theory of aging: The “free radical” diseases , 1984, AGE.

[30]  G. Ghai,et al.  Myocardial alterations due to free-radical generation. , 1984, The American journal of physiology.

[31]  G. Cohen.  Oxy-radical toxicity in catecholamine neurons. , 1984, Neurotoxicology.

[32]  G. Cohen.  Catalase, Glutathione Peroxidase, Superoxide Dismutase, and Cytochrome P-450 , 1983 .

[33]  I. Fridovich.  Superoxide radical: an endogenous toxicant. , 1983, Annual review of pharmacology and toxicology.

[34]  P. Sinet.  Metabolism of Oxygen Derivatives in Down's Syndrome * , 1982, Annals of the New York Academy of Sciences.

[35]  G Jonsson,et al.  Chemical neurotoxins as denervation tools in neurobiology. , 1980, Annual review of neuroscience.

[36]  B Chance,et al.  Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.